HSE P&T Portfolio: Humira

Article

Adalimumab(Humira)for use in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease-modifying antirheumatic drugs.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.